Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based CompensationShares RepurchasedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Kewaunee Scientific (KEQU) Gains from Investment Securities (2016 - 2026)

Kewaunee Scientific (KEQU) has 4 years of Gains from Investment Securities data on record, last reported at $72000.0 in Q4 2025.

  • For Q4 2025, Gains from Investment Securities rose 2.86% year-over-year to $72000.0; the TTM value through Oct 2025 reached $4.0 million, changed N/A, while the annual FY2025 figure was $4.0 million, 1886.0% up from the prior year.
  • Gains from Investment Securities reached $72000.0 in Q4 2025 per KEQU's latest filing, up from $14000.0 in the prior quarter.
  • Across five years, Gains from Investment Securities topped out at $3.9 million in Q2 2025 and bottomed at $11000.0 in Q3 2024.